4.8 Article

CHIP-mediated degradation of transglutaminase 2 negatively regulates tumor growth and angiogenesis in renal cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models

Bo Mi Ku et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)

Article Urology & Nephrology

Transglutaminase 2 Accelerates Vascular Calcification in Chronic Kidney Disease

Neal X. Chen et al.

AMERICAN JOURNAL OF NEPHROLOGY (2013)

Article Biochemistry & Molecular Biology

Transglutaminase 2 inhibition found to induce p53 mediated apoptosis in renal cell carcinoma

Bo Mi Ku et al.

FASEB JOURNAL (2013)

Article Biochemistry & Molecular Biology

The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity

I. Paul et al.

ONCOGENE (2013)

Article Biochemistry & Molecular Biology

The Chaperone-assisted E3 Ligase C Terminus of Hsc70-interacting Protein (CHIP) Targets PTEN for Proteasomal Degradation

Syed Feroj Ahmed et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

A Unique Role for Heat Shock Protein 70 and Its Binding Partner Tissue Transglutaminase in Cancer Cell Migration

Lindsey K. Boroughs et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Ubiquitin Ligase CHIP Induces TRAF2 Proteasomal Degradation and NF-κB Inactivation to Regulate Breast Cancer Cell Invasion

Kang Won Jang et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2011)

Article Oncology

The transglutaminase 2 gene is aberrantly hypermethylated in glioma

Lisa M. Dyer et al.

JOURNAL OF NEURO-ONCOLOGY (2011)

Review Biochemistry & Molecular Biology

Transglutaminase 2: a multi-functional protein in multiple subcellular compartments

Donghyun Park et al.

AMINO ACIDS (2010)

Article Biochemistry & Molecular Biology

Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90

Shan Yan et al.

EMBO JOURNAL (2010)

Article Transplantation

Arterial calcification in patients with chronic kidney disease

Nadezda Koleganova et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)

Article Biochemistry & Molecular Biology

Transglutaminase 2 protects against ischemic insult, interacts with HIF1β, and attenuates HIF1 signaling

Anthony J. Filiano et al.

FASEB JOURNAL (2008)

Article Biochemistry & Molecular Biology

CHIP deficiency decreases longevity, with accelerated aging phenotypes accompanied by altered protein quality control

Jin-Na Min et al.

MOLECULAR AND CELLULAR BIOLOGY (2008)

Article Biochemistry & Molecular Biology

Chaperone-dependent stabilization and degradation of p53 mutants

P. Muller et al.

ONCOGENE (2008)

Article Urology & Nephrology

Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease

Tim S. Johnson et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)

Article Oncology

Implications of tissue transglutaminase expression in malignant melanoma

Jansina Y. Fok et al.

MOLECULAR CANCER THERAPEUTICS (2006)

Review Oncology

Searching for the hereditary causes of renal-cell carcinoma

CP Pavlovich et al.

NATURE REVIEWS CANCER (2004)

Review Oncology

Molecular basis of the VHL hereditary cancer syndrome

WG Kaelin

NATURE REVIEWS CANCER (2002)

Article Biochemistry & Molecular Biology

CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein

S Murata et al.

EMBO REPORTS (2001)

Article Cell Biology

The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation

GC Meacham et al.

NATURE CELL BIOLOGY (2001)